Risk Factor Analysis of Urinary Tract Infection by Cefotaxime-Resistant Escherichia coli and Klebsiella pneumoniae: A Simple and Effective Analysis Using the National Health Insurance Data Sharing Service
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study aims to analyze the risk factors for urinary tract infection (UTI) by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae, using data from the National Health Insurance Data Sharing Service. Methods: A retrospective case-control study was conducted to analyze the risk factors during 11 years (2010–2020). Study groups were selected based on the laboratory data of the hospital, which comprised 3,638 and 877 cases of cefotaxime-resistant E. coli and K. pneumoniae , respectively. Controls comprised 8,994 and 1,573 cases of cefotaxime-nonresistant (intermediate or susceptible) E. coli and K. pneumoniae, respectively. Clinical and socioeconomical features were obtained from the National Health Insurance service data. Results: In a multivariate analysis of risk factors for UTI by cefotaxime-resistant E. coli, the odds ratio (OR) of the male sex was 1.335 (95% confidence interval, 1.204–1.480), age 0–9 years was 1.794 (1.468–2.191), chronic renal disease was 1.227 (1.062–1.417), and hemodialysis was 1.685 (1.255–2.262). Moreover, the ORs of L-tube, central venous pressure catheter, and Foley catheter use were 1.204 (1.047–1.385), 1.332 (1.156–1.534), and 1.473 (1.316–1.649), respectively; the OR of previous antimicrobial use was 1.103 (1.009–1.206) and that of healthcare facility use was 1.782 (1.576–2.014). In a multivariate analysis of risk factors for UTI by cefotaxime-resistant K. pneumoniae, OR of the male sex was 1.460 (1.199–1.778), liver disease was 1.295 (1.037–1.617), and hemodialysis was 2.046 (1.263–3.315). The ORs of L-tube and Foley catheter use were 2.329 (1.861–2.915) and 1.793 (1.431–2.246), respectively, and the OR of the healthcare facility use was 1.545 (1.161–2.056). Conclusion: In this study, the risk factors for UTI caused by cefotaxime-resistant E. coli or K. pneumoniae were analyzed based on the data of a specific healthcare facility linked to the National Health Insurance system. We suggest that it is a simple and effective way to elucidate risk factors of infections caused by major antimicrobial-resistant pathogens.
Abstract
Background: This study aims to analyze the risk factors for urinary tract infection (UTI) by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae, using data from the National Health Insurance Data Sharing Service. Methods: A retrospective case-control study was conducted to analyze the risk factors during 11 years (2010–2020). Study groups were selected based on the laboratory data of the hospital, which comprised 3,638 and 877 cases of cefotaxime-resistant E. coli and K. pneumoniae , respectively. Controls comprised 8,994 and 1,573 cases of cefotaxime-nonresistant (intermediate or susceptible) E. coli and K. pneumoniae, respectively. Clinical and socioeconomical features were obtained from the National Health Insurance service data. Results: In a multivariate analysis of risk factors for UTI by cefotaxime-resistant E. coli, the odds ratio (OR) of the male sex was 1.335 (95% confidence interval, 1.204–1.480), age 0–9 years was 1.794 (1.468–2.191), chronic renal disease was 1.227 (1.062–1.417), and hemodialysis was 1.685 (1.255–2.262). Moreover, the ORs of L-tube, central venous pressure catheter, and Foley catheter use were 1.204 (1.047–1.385), 1.332 (1.156–1.534), and 1.473 (1.316–1.649), respectively; the OR of previous antimicrobial use was 1.103 (1.009–1.206) and that of healthcare facility use was 1.782 (1.576–2.014). In a multivariate analysis of risk factors for UTI by cefotaxime-resistant K. pneumoniae, OR of the male sex was 1.460 (1.199–1.778), liver disease was 1.295 (1.037–1.617), and hemodialysis was 2.046 (1.263–3.315). The ORs of L-tube and Foley catheter use were 2.329 (1.861–2.915) and 1.793 (1.431–2.246), respectively, and the OR of the healthcare facility use was 1.545 (1.161–2.056). Conclusion: In this study, the risk factors for UTI caused by cefotaxime-resistant E. coli or K. pneumoniae were analyzed based on the data of a specific healthcare facility linked to the National Health Insurance system. We suggest that it is a simple and effective way to elucidate risk factors of infections caused by major antimicrobial-resistant pathogens.
참고문헌 (12)
- Gupta K, "Urinary tract infection", Ann Intern Med, 167, pp.ITC49~ITC6 (2017)
- Jung C, "The etiology and management of recurrent urinary tract infections in postmenopausal women", Climacteric, 22, pp.242~249 (2019)
- Millner R, "Urinary tract infections", Pediatr Clin North Am, 66, pp.1~13 (2019)
- Lee H, "Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS", Euro Surveill, 23, pp.1800047~ (2018)
- Kim D, "Major bloodstream infectioncausing bacterial pathogens and their antimicrobial resistance in South Korea, 2017-2019:Phase I report from Kor-GLASS", Front Microbiol, 12, pp.799084~ (2022)
- 김경훈, "Charlson 동반질환의 ICD-10 알고리즘 예측력 비교연구", 예방의학회지, 43(1), pp.42~49 (2010), 대한예방의학회
- van Driel AA, "Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period", Eur J Clin Microbiol Infect Dis, 38, pp.2151~2158 (2019)
- Rawat D, "Extended-spectrum β-lactamases in gram negative bacteria", J Glob Infect Dis, 2, pp.263~274 (2010)
- Al-Tamimi M, "Effective oral combination treatment for extended-spectrum beta-lactamase-producing Escherichia coli", Microb Drug Resist, 25, pp.1132~1141 (2019)
- Holmes CL, "Pathogenesis of Gram-negative bacteremia", Clin Microbiol Rev, 34, pp.e00234-20~ (2021)
- Larramendy S, "Risk factors of extended-spectrum beta-lactamases-producing Escherichia coli community acquired urinary tract infections : a systematic review", Infect Drug Resist, 13, pp.3945~3955 (2020)
- Ben-Ami R, "A multinational survey of risk factors for infection with extended-spectrum ß-lactamaseproducing Enterobacteriaceae in nonhospitalized patients", Clin Infect Dis, 49, pp.682~690 (2009)